The regulatory role of AT1 receptor on activated HSCs in hepatic fibrogenesis: Effects of RAS inhibitors on hepatic fibrosis induced by CCl4

Table 1 Effects of RAS inhibitors on rat serum levels of ALT and AST

	n	ALT (U/L)	AST (U/L)
Control	10	99.50 ± 18.78	244.50 ± 46.52
Model	7	1863.29 ± 893.68a	2680.86 ± 1039.12a
Enalapril	7	466.14 ± 132.64b	785.29 ± 262.40b
Losartan	8	535.25 ± 200.78b	777.50 ± 270.32b
Enalapril+losartan	8	863.87 ± 345.75c	449.60 ± 130.36b

^aP < 0.01 vs comtrol;

^bP < 0.01 vs Model;

^cP < 0.05 vs Model.